Dechra is an international specialist veterinary pharmaceuticals and related products business. Our expertise is in the development, manufacture, and sales and marketing of high quality products exclusively for veterinarians worldwide.
We have made excellent progress since setting our priorities for each Growth Driver in 2013.
Commenced trading in
Italy
Percentage of revenue made from outside Europe
Underlying operating profit margin
Commenced trading in
Canada and Poland
Acquired
Genera
Entry into poultry vaccines
Acquired
Putney
Transformational US deal
Acquired
Apex
Access to Australian CAP market
Number of countries distributed to
Number of countries with own sales and marketing organisations
Acquired 33% of
Medical Ethics
Access to novel product development
Acquired
RxVet
Access to New Zealand
Acquired
AST Farma
Strengthens Dutch market position and provides direct-to-vet relationship
Le Vet
Adds to EU product portfolio
Number of product registrations